U.S. federal trademark · Serial No. 98096556
Electronic platform utilized for pharmaceutical drug development services; medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment; development of translational research tools for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.